SEATTLE--(BUSINESS WIRE)--Jan. 9, 2006--Pacific Biometrics, Inc. (OTCBB:PBME) (“PBI”) has been awarded a contract with a top biopharmaceutical company (the “Sponsor”) to provide essential laboratory data for a global Phase IV arthritis program. This contract is part of a series of studies related to the clinical development of new indications for a major biological treatment for arthritis.
